Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3.
Open Access
- 1 April 1990
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 144 (7) , 2771-2780
- https://doi.org/10.4049/jimmunol.144.7.2771
Abstract
We have examined the receptor-ligand interactions and the method of phagocytosis of virulent Mycobacterium tuberculosis by human monocytes. mAb against complement receptors (CR) inhibit adherence and phagocytosis of M. tuberculosis in fresh nonimmune serum. A mAb against the type 1 CR (CR1) inhibits adherence of M. tuberculosis by 40 +/- 5%, and three different mAb against the type 3 CR (CR3) each inhibit adherence by 39 +/- 5% to 47 +/- 4%. A mAb against CR1 used in combination with one of the three mAb against CR3 inhibits adherence by up to 64 +/- 7%. Most strikingly, two mAb used in combination against CR3 inhibit adherence by up to 81 +/- 2%. mAb against other monocyte surface Ag do not significantly influence adherence. In like fashion, mAb against CR but not other monocyte surface Ag inhibit adherence of preopsonized M. tuberculosis in the presence of heat-inactivated serum. By electron microscopy, monocytes ingest all M. tuberculosis that adhere in the presence of nonimmune serum; mAb against CR3 markedly inhibit ingestion. In contrast to CR, the FcR and the beta-glucan-inhibitable receptor for zymosan play little or no role in mediating M. tuberculosis adherence or ingestion. Adherence of M. tuberculosis is serum-dependent, requiring greater than or equal to 2.5% serum for optimal adherence. Heat inactivation of serum markedly reduces adherence of M. tuberculosis (75.5 +/- 7%) and preopsonization of bacteria enhances adherence by 2.9 +/- 0.4-fold. Adherence is also markedly reduced in C3- or factor B-depleted serum; repletion with C3 or factor B increases adherence by 2.1 +/- 0.4-fold and 1.86 +/- 0.05-fold, respectively. Fab anti-C3 IgG markedly inhibits monocyte adherence of preopsonized M. tuberculosis (71 +/- 1%). C component C3 is fixed to M. tuberculosis by the alternative C pathway as determined by a whole bacterial cell ELISA. Human monocytes ingest M. tuberculosis by conventional phagocytosis as viewed by electron microscopy. This study demonstrates that human monocyte CR1 and CR3 mediate phagocytosis of M. tuberculosis and C component C3 in serum is acting as the major bacterium-bound ligand.This publication has 39 references indexed in Scilit:
- Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor.The Journal of Experimental Medicine, 1982
- Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus.The Journal of Experimental Medicine, 1982
- Biochemical characterization of the sixth component (C6) of human complementBiochemistry, 1982
- Legionnaires' Disease Bacterium (Legionella pneumophila) Multiplies Intracellularly in Human MonocytesJournal of Clinical Investigation, 1980
- A monoclonal antibody reactive with human peripheral blood monocytes.The Journal of Immunology, 1980
- Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.Journal of Clinical Investigation, 1980
- Leishmania donovani: Promastigote-macrophage surface interactions in vitroExperimental Parasitology, 1979
- Effects of immobilized immune complexes on Fc- and complement-receptor function in resident and thioglycollate-elicited mouse peritoneal macrophages.The Journal of Experimental Medicine, 1979
- The Alternative Pathway C3/C5 Convertase: Chemical Basis of Factor B ActivationThe Journal of Immunology, 1979
- Trypanosoma cruzi: mechanism of entry and intracellular fate in mammalian cells.The Journal of Experimental Medicine, 1976